Literature DB >> 10915117

UK licence for cisapride suspended

.   

Abstract

Entities:  

Year:  2000        PMID： 10915117      PMCID： PMC1118265     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  A comparison of the pharmacokinetics of two dosing regimens of cisapride and their effects on corrected QT interval in premature infants.

Authors:  Filip Cools; Avram Benatar; Els Bruneel; Claire Theyskens; Adel Bougatef; Ann Casteels; Yvan Vandenplas
Journal:  Eur J Clin Pharmacol       Date:  2003-04-01       Impact factor: 2.953

Review 2.  Lansoprazole: an update of its place in the management of acid-related disorders.

Authors:  A J Matheson; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Stereoselective pharmacokinetics of cisapride in healthy volunteers and the effect of repeated administration of grapefruit juice.

Authors:  Z Desta; K T Kivistö; J J Lilja; J T Backman; N Soukhova; P J Neuvonen; D A Flockhart
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

Review 4.  Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.

Authors:  Will Carroll; Jessica Green; Francis J Gilchrist
Journal:  Cochrane Database Syst Rev       Date:  2021-12-22

5.  Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom.

Authors:  Peter Layer; Jutta Keller; Helena Loeffler; Andreas Kreiss
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

6.  Machine Learning of Human Pluripotent Stem Cell-Derived Engineered Cardiac Tissue Contractility for Automated Drug Classification.

Authors:  Eugene K Lee; David D Tran; Wendy Keung; Patrick Chan; Gabriel Wong; Camie W Chan; Kevin D Costa; Ronald A Li; Michelle Khine
Journal:  Stem Cell Reports       Date:  2017-10-12       Impact factor: 7.765

Review 7.  Application of the Pluripotent Stem Cells and Genomics in Cardiovascular Research-What We Have Learnt and Not Learnt until Now.

Authors:  Michael Simeon; Seema Dangwal; Agapios Sachinidis; Michael Xavier Doss
Journal:  Cells       Date:  2021-11-10       Impact factor: 6.600

Review 8.  Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.

Authors:  Jessica Green; Francis J Gilchrist; Will Carroll
Journal:  Cochrane Database Syst Rev       Date:  2018-06-12

9.  Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.

Authors:  Andreas Vilhelmsson; Courtney Davis; Shai Mulinari
Journal:  PLoS Med       Date:  2016-01-26       Impact factor: 11.069
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.